What do polymorphisms tell us about the mechanisms of COPD?

被引:14
|
作者
Li, Yan [1 ,2 ]
Cho, Michael H. [1 ,2 ,3 ]
Zhou, Xiaobo [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
OBSTRUCTIVE PULMONARY-DISEASE; GENOME-WIDE ASSOCIATION; HEDGEHOG-INTERACTING PROTEIN; PLURIPOTENT STEM-CELLS; LUNG-FUNCTION; CIGARETTE-SMOKE; GENETIC-VARIATION; BETA-CATENIN; FUNCTIONAL DISSECTION; TELOMERASE MUTATIONS;
D O I
10.1042/CS20160718
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
COPD (chronic obstructive pulmonary disease) is characterized by irreversible lung airflow obstruction. Cigarette smoke is the major risk factor for COPD development. However, only a minority number of smokers develop COPD, and there are substantial variations in lung function among smokers, suggesting that genetic determinants in COPD susceptibility. During the past decade, genome-wide association studies and exome sequencing have been instrumental to identify the genetic determinants of complex traits, including COPD. Focused studies have revealed mechanisms by which genetic variants contribute to COPD and have led to novel insights in COPD pathogenesis. Through functional investigations of causal variants in COPD, from the proteinase-antiproteinase theory to emerging roles of developmental pathways (such as Hedgehog and Wnt pathways) in COPD, we have greatly expanded our understanding on this complex pulmonary disease. In this review, we critically review functional investigations on roles of genetic polymorphisms in COPD, and discuss future challenges and opportunities in discovering novel mechanisms of functional variants.
引用
收藏
页码:2847 / 2863
页数:17
相关论文
共 50 条
  • [31] The Miracles in the Gospels: What Do They Tell Us About Jesus?
    Carter, Tim
    [J]. THEOLOGY, 2016, 119 (02) : 154 - 155
  • [32] What do olfactory preferences tell us about personality
    Reshef, Neta
    Snitz, Kobi
    Sobel, Noam
    [J]. CHEMICAL SENSES, 2016, 41 (09) : E192 - E192
  • [33] What do recent trials tell us about statins?
    Goldberg, AC
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 : S67 - S69
  • [34] What do readmissions tell us about the quality of care?
    Swart, E
    [J]. GESUNDHEITSWESEN, 2004, 66 (8-9) : 643 - 643
  • [35] What trials do and do not tell us about treatments for severe asthma
    Quint, Jennifer K.
    Shah, Pallav L.
    [J]. LANCET, 2024, 403 (10423): : 224 - 226
  • [36] What indicators do (or do not) tell us about Regional Innovation Systems
    Jon Mikel Zabala-Iturriagagoitia
    Fernando Jiménez-Sáez
    Elena Castro-Martínez
    Antonio Gutiérrez-Gracia
    [J]. Scientometrics, 2007, 70 : 85 - 106
  • [37] What indicators do (or do not) tell us about Regional Innovation Systems
    Zabala-Iturriagagoitia, Jon Mikel
    Jimenez-Saez, Fernando
    Castro-Martinez, Elena
    Gutierrez-Gracia, Antonio
    [J]. SCIENTOMETRICS, 2007, 70 (01) : 85 - 106
  • [38] What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?
    Buzzard, Katherine A.
    Broadley, Simon A.
    Butzkueven, Helmut
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (10) : 12665 - 12709
  • [39] What can naturally occurring mutations tell us about the pathogenesis of COPD?
    Marciniak, S. J.
    Lomas, D. A.
    [J]. THORAX, 2009, 64 (04) : 359 - 364
  • [40] What do expression dynamics tell us about the mechanism of transcription?
    Larson, Daniel R.
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (05) : 591 - 599